Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mu-Hsin Chang

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|July 11, 2013
Expression of GOLM1 correlates with prognosis in human hepatocellular carcinomaMing-Huang Chen, Yi-Hua Jan, Peter Mu-Hsin Chang, et al.
Oncology Letters|July 3, 2018
Nab-paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stromaPeter Mu-Hsin Chang, Chi-Tung Cheng, Ren-Chin Wu, et al.
Journal of the Chinese Medical Association : JCMA|July 26, 2008
Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancerPeter Mu-Hsin Chang, Hao-Wei Teng, Po-Min Chen, et al.
Postgraduate Medicine|August 14, 2020
Predictors of early progression after curative resection followed by platinum-based adjuvant chemoradiotherapy in oral cavity squamous cell carcinomaHsueh-Ju Lu, Szu-Wen Tseng, Chih-Yu Peng, et al.
Urologic Oncology|August 10, 2025
Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world studyYi-Chieh Chen, Jiun-I Lai, Yen-Hwa Chang, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2008
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II studyPeter Mu-Hsin Chang, Po-Min Chen, Pen-Yuan Chu, et al.
International Journal of Oncology|August 13, 2008
Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcomePeter Mu-Hsin Chang, Po-Min Chen, Shie-Liang Hsieh, et al.
Journal of Ethnopharmacology|December 28, 2018
Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophyJing-Ming Chen, Ting-Ting Yang, Tai-Shan Cheng, et al.
Annals of Surgical Oncology|June 19, 2013
High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resectionPeter Mu-Hsin Chang, Yi-Chen Yeh, Tzu-Chi Chen, et al.
Hepato-Gastroenterology|April 28, 2015
External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinomaSan-Chi Chen, Ming-Huang Chen, Chung-Pin Li, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|July 11, 2013
Expression of GOLM1 correlates with prognosis in human hepatocellular carcinomaMing-Huang Chen, Yi-Hua Jan, Peter Mu-Hsin Chang, et al.
Oncology Letters|July 3, 2018
Nab-paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stromaPeter Mu-Hsin Chang, Chi-Tung Cheng, Ren-Chin Wu, et al.
Journal of the Chinese Medical Association : JCMA|July 26, 2008
Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancerPeter Mu-Hsin Chang, Hao-Wei Teng, Po-Min Chen, et al.
Postgraduate Medicine|August 14, 2020
Predictors of early progression after curative resection followed by platinum-based adjuvant chemoradiotherapy in oral cavity squamous cell carcinomaHsueh-Ju Lu, Szu-Wen Tseng, Chih-Yu Peng, et al.
Urologic Oncology|August 10, 2025
Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world studyYi-Chieh Chen, Jiun-I Lai, Yen-Hwa Chang, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2008
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II studyPeter Mu-Hsin Chang, Po-Min Chen, Pen-Yuan Chu, et al.
International Journal of Oncology|August 13, 2008
Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcomePeter Mu-Hsin Chang, Po-Min Chen, Shie-Liang Hsieh, et al.
Journal of Ethnopharmacology|December 28, 2018
Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophyJing-Ming Chen, Ting-Ting Yang, Tai-Shan Cheng, et al.
Annals of Surgical Oncology|June 19, 2013
High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resectionPeter Mu-Hsin Chang, Yi-Chen Yeh, Tzu-Chi Chen, et al.
Hepato-Gastroenterology|April 28, 2015
External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinomaSan-Chi Chen, Ming-Huang Chen, Chung-Pin Li, et al.
Pageof 10